Form 8-K - Current report:
SEC Accession No. 0001564590-20-026550
Filing Date
2020-05-21
Accepted
2020-05-21 16:09:14
Documents
12
Period of Report
2020-05-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K nbix-8k_20200519.htm   iXBRL 8-K 120682
  Complete submission text file 0001564590-20-026550.txt   249738

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nbix-20200519.xsd EX-101.SCH 5784
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbix-20200519_lab.xml EX-101.LAB 18732
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbix-20200519_pre.xml EX-101.PRE 11179
9 EXTRACTED XBRL INSTANCE DOCUMENT nbix-8k_20200519_htm.xml XML 3416
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 20901951
SIC: 2836 Biological Products, (No Diagnostic Substances)